Recent cuts to the federal workforce could negatively impact cancer research and public health for years to come, researchers say.

A measles outbreak in Texas has grown to 159 cases, and the CDC has sent a team to help local health officials respond.

Researchers sought to evaluate differences in ctDNA profiles, use of targeted treatments, and overall survival between Black and White patients with metastatic breast cancer.

The FDA has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt (denosumab-bmwo), a biosimilar to Xgeva (denosumab).

Though President Trump denied having any connection to Project 2025 on the campaign trail, he has pushed its health policy ...

The updated guidelines note that patients with stage IV NSCLC who have EGFR exon 19 deletions or exon 21 L858R substitutions can receive osimertinib plus platinum doublet chemotherapy or amivantamab ...

HHS Secretary Robert F. Kennedy Jr. has rescinded the HHS policy of requiring new rules and regulations to be open to public comment before they are implemented.

The FDA has approved Tevimbra (tislelizumab) for use in combination with chemotherapy as first-line treatment for unresectable or metastatic, PD-L1-positive ESCC.

Dr Francis Collins, the famed geneticist who led the National Institutes of Health for 12 years, has stepped down.

Using AI-enabled tools to automatically deny more and more needed care is not the reform of prior authorization physicians and patients are calling for,” said AMA President Bruce A. Scott, MD.

Discontinuing tyrosine kinase inhibitor maintenance after extended complete molecular response should only be attempted as part of a clinical trial, the researchers say.

This is a public health crisis that exacerbates overdiagnosis and threatens the sustainability of health systems,” said Ray Moynihan, PhD.